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A B S T R A C T 
Type 2 diabetes mellitus (T2DM) is an alarming health care concern the world over affecting more-than 220 million 
people  worldwide  according  to  World  Health  Organization.  Kidney  disease  in  diabetic  patients  is  clinically 
characterized  by  increasing  rates  of  urinary  albumin  excretion  (UAE),  starting  from  normoalbuminuria,  which 
progresses  to  microalbuminuria,  macroalbuminuria  and  eventually  to  End-Stage  Renal  Disease.  Diabetic 
nephropathy  has  been  categorized  into  stages  based  on  the  values  of  urinary  albumin  excretion  and  estimated 
glomerular  filtration  (eGFR).  There  is  accumulating  evidence  suggesting  that  the  risk  for  developing  diabetes 
nephropathy and cardiovascular disease starts when UAE values are still within normoalbuminic range. Objective: 
To study the prevalence and stages of nephropathy in T2DM patients and to compare albumin levels with glycemic 
control in rural population. Methodology: Cross-sectional study was carried out from January 2011 to April 2012 
among diabetic patients attending General Medicine department in RL Jalappa Hospital. Random blood sample and 
spot urine sample was collected for analysis and the data was collected in a predesigned, pretested semi-structured 
questionnaire.  Results:  The  prevalence  of  diabetic  nephropathy  in  our  study  was  37.02%.  The  prevalence 
microalbuminuria was 30.79% in males and 24.46% in females. The prevalence of overt nephropathy was 9.27% in 
males and 6.73% in females. Around 62.97% were in microalbuminuric range.  75.76% of the patients had poor 
glycemic control, but among patients with poor glycemic control 79.78% had overt nephropathy and 86.80% had 
microalbuminuria. Among patients with good glycemic control 20.28% had overt nephropathy and 13.19% had 
microalbuminuria. Conclusion: Microalbuminuria was earliest sign in Diabetic Nephropathy (DN). Progression of 
DN  can  be  prevented  on  early  detection.  Poor  glycemic  control  and  duration  of  diabetes  was  associated  with 
increase in UAE level and progression of Chronic Kidney Disease. Screening for DN at the time of diagnosis in 
T2DM and measures to reduce albuminuria at earliest could prevent further progression of DN in patients with 
T2DM 
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Introduction: Type 2 diabetes mellitus (T2DM) is an 
alarming  health  care  concern  the  world  over.
1 
According to the World Health Organization (WHO), 
T2DM  affects  more  than  220  million  people 
worldwide and is projected to reach 370 million by 
2030.  India  has  the  largest  number  of  diabetic 
patients  in  the  world,  estimated  to  be  about  40.9 
million in the year 2007 and expected to increase to 
about 69.9 million by the year 2025.
2 About a third of 
these  patients  are  likely  to  develop  diabetic 
nephropathy  and  progressive  chronic  kidney 
disease(CKD).
3 
 
The  propensity  of  development  of  nephropathy  in 
diabetic patients also depends on other demographic 
factors  and  racial  differences  have  been  seen  to  
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influence the prevalence of diabetic nephropathy.
4,5 In 
the United States, the risk of end stage renal disease 
(ESRD)  is  reported  to  be  higher  among  Hispanics 
and Afro-Americans than among Caucasian subjects 
even  after  adjusting  confounding  factors.
6,7  Asian 
subject have significantly (P<0.01) higher prevalence 
(52.6%) of diabetic ESRD when compared with the 
Caucasians (36.2%).
8      
 
Kidney  disease  in  diabetic  patients  is  clinically 
characterized by increasing rates of urinary albumin 
excretion  (UAE),  starting  from  normoalbuminuria, 
which  progresses  to  microalbuminuria, 
macroalbuminuria,  and  eventually  to  ESRD.
9 
Microalbuminuria is the earliest clinically detectable 
stage of diabetic kidney disease at which appropriate 
interventions can retard or reverse the progression of 
the disease.
10 
 
Diabetic nephropathy (DN) has been categorized into 
stages based on the values of UAE (ADA, 2004) and 
estimated  glomerular  filteration  rate  (eGFR).
11,12 
There is a accumulating evidence suggesting that the 
risk  for  developing  DN  and  cardiovascular  disease 
starts  when  UAE  values  are  still  within 
normoalbuminic range.
13,14,15,16 
 
In this regard, the study was designed to assess the 
prevalence  and  stages  of  nephropathy  in  T2DM 
patients and to compare albumin levels with glycemic 
control in a rural population thereby the progression 
of  T2DM  patients  to  DN  can  be  constrained  early 
through screening them for UAE and eGFR. 
 
Material  and  Methods:  Cross-sectional  study  was 
conducted  in  the  department  of  General  Medicine, 
RL Jalappa Hospital and Research Center, attached to 
Sri Deveraj Urs Medical College, Kolar. The diabetic 
patients  attending  medicine  out-patient  department, 
from January 2011 to April 2012 were included.  All 
the patients were interviewed with pre-designed, pre-
tested,  semi-structured  questionnaire.  Patients  with 
known renal failure, urinary tract infection, hematuria, 
acute febrile illness, vigorous exercise and short term 
pronounced  hyperglycemia,  uncontrolled 
hypertension  and  heart  failure  were  excluded  from 
the  study.  Informed  consent  was  obtained  by  the 
subjects  and  Institutional  Ethical  Clearance  was 
obtained for the study.  
Random blood sample was taken for estimation 
of serum creatinine using a Hitachi 912 auto-analyzer 
(Roche  Diagnostics,  Mannheim,  Germany)  for 
calculation  of  Glomerular  Filtration  Rate  (GFR). 
GFR is estimated by prediction equation that is taken 
into account serum creatinine concentration and age, 
sex, race and body size. The recommended equation 
by  the  national  kidney  foundation  is  that  of  the 
modified  diet  in  renal  disease  (MDRD),  which 
estimates the GFR as follows.
17 
GFR  (ml/min/1.73  m
2)  =  186*[serum  creatinine 
(mg/dl)  -  1.154*age(yr)  -  0.203*(0.742,  if 
female)*(1.210,  if  African  American)]  and  later 
eGFR were classified into stages.
18 
 
Glycosylated  hemoglobin  HbA1C  was  analyzed  by 
the high-performance liquid chromatography method 
using  the  Variant  machine  (Bio-red,  Hercules  and 
California). Glycemic control was considered as good 
in patients with HbA1c< 7 and poor in patients with 
HbA1c  ≥  7.
19  Albuminuria  concentration  was 
measured  in  a  spot  urine  sample  using 
immunoturbidometric  assay  (Hitachi  902  auto-
analyzer;  Roche  Diagnostics).  Micro-albuminuria 
was diagnosed if the albumin excretion was between 
30  and  299  mcg/mg  creatinine.  Overt  nephropathy 
was  diagnosed  if  albumin  excretion  was  ± 
300mcg/mg creatinine. 
20 The report obtained from 
the sample on analysis was scrutinized by the NABL 
trained technician and a qualified biochemist before it 
is  being  dispatched  from  the  laboratory  as  a  data 
quality control procedure. 
 
Statistical analysis was performed by SPSS software. 
Qualitative  data  was  expressed  in  proportions  and 
quantitative data in mean and standard deviation. Test 
of significance was done with chi-square and student 
t-test.  Correlation  analysis  was  carried  out  and 
correlation coefficient was calculated. P value <0.05 
was considered statistically significant.  
 
Results:  A total of 821 T2DM patients (539 males 
and 282 females) were studied. The mean age in the 
study group was 54.75 years, mean serum creatinine 
was  0.98,  mean  eGFR  was  91.75,  mean  UAE  was 
95.21 and mean HbA1c was 9.06 [Table-1]. 
 
Table-1: Clinical characteristics of Type-2 diabetic 
patients 
Parameter  Figures (Mean±SD) 
Age 
Serum creatinine 
eGFR*  
UAE** 
HbA1c***  
54.75 ±11.98 
0.9755 ± 0.62 
91.7524 ± 32.11 
95.2096 ± 318.41 
9.0627 ± 2.40 
*estimated Glomerular Filtration Rate, **Urinary 
Albumin Excretion, ***Glycosylated Haemoglobin 
 
The most common stage of DN as per eGFR was in 
stage-1 (51.64%), followed by 33.86%, 11.57%, 2.07% 
and 0.85% patients in stage 2,3,4 and 5 respectively 
[Table-2]. The  prevalence  of  DN  was  more  among  
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males compared to females among all the stages as 
per eGFR [Figure-1].  
 
Figure-1: Prevalence of Diabetic Nephropathy 
among Males and Females (eGFR) 
*estimated Glomerular Filtration Rate 
 
In  Table-3,  the  prevalence  of  diabetic  nephropathy 
was  37.02%  (8.40%  was  overt  nephropathy  and 
28.62% was microalbuminuria) and 62.97% were in 
normoalbuminuric range. 75.76% of the patients had 
poor  glycemic  control  and  24.33%  had  good 
glycemic  control.  A  statistically  significant 
association  was  observed  between  UAE  and 
glycosylated  haemoglobin.  The  prevalence 
microalbuminuria was 30.79% in males and 24.46% 
in females and the prevalence of overt nephropathy 
was 9.27% in males and 6.73% in females [Figure-2].  
Table-4 depicts maximum subjects i.e., 52.25% had 
T2DM  since  five  years.  The  prevalence  of  overt 
nephropathy increased with the duration of diabetes 
and a significant association was observed between 
duration of diabetes and UAE.    
 
Table-2: Stages of Diabetic Nephropathy in Males and Females 
Stages of nephropathy  eGFR* 
ml/min/1.73m
2  Males  Females  Total 
Stage 1  ≥90  278 (51.57)   146( 51.77)  424(51.64) 
Stage 2  60-89  192(35.62)  86 (30.49)  278(33.86) 
Stage 3  30-59  52(9.64)  43(15.24)  95(11.57) 
Stage 4  15-29  11(2.04)  6(2.12)  17(2.07) 
Stage 5  <15  6(1.11)  1(.35)  7(0.85) 
Total  539(99.98)  282(99.97)  821(99.99) 
Figures in parenthesis indicates percentages, *estimated Glomerular Filtration Rate 
 
Table-3: Urine Albumin Excretion of type 2 diabetes mellitus subjects in relation to glycemic status  
UAE* 
(mcg/mg of creatinine) 
HbA1c**<7 
n=199 
HbA1c**≥7 
n=622  Total 
<30  154 (29.78)  363(70.20)  517(62.97) 
30-299  31(13.19)  204(86.80)  235(28.62) 
>300  14(20.28)  55(79.78)  69(8.40) 
Figures in parenthesis indicates percentages, * Urinary Albumin Excretion,** Glycosylated Haemoglobin
 
X
2= 24.87, df =2, P< 0.001The relationship between 
HbA1C with eGFR and UAE level of the T2DM are 
revealed  in  Figure-3  &  4  respectively.  There  was 
statistically significant correlation observed between 
HbA1C  with  eGFR  and  UAE  levels.    As  HbA1c 
values  increased  a  rise  in  the  UAE  values  was 
observed, whereas eGFR values decreased.  
 
Discussion:The  fact  that  there  is  a  relationship 
between  nephropathy  and  diabetes  has  been 
established.
11 From the results obtained in this study, 
28.62%  and  8.40%  of  the  diabetic  subjects  have 
albumin levels greater than the acceptable upper limit 
of  normal  (30  mg/l).  This  implies  that 
microalbuminuria and macro albuminuria is prevalent 
amongst the diabetes. In this study, we observed 8.40%  
 
 
had overt nephropathy.  
 
Table-4:  Duration  of  diabetes  and  urine  albumin 
levels 
Diabetes 
Duration 
in Years 
UAE* 
(mcg/mg creatinine)  Total 
<30  30-299  ±300 
<5  312 
(60.23) 
114 
(48.31)  3 (4.48)  429 
(52.25) 
5-10  182 
(35.14) 
107 
(45.34) 
13 
(19.40) 
302 
(36.78) 
>10  24 
(4.63) 
15 
(6.36) 
51 
(76.12) 
90 
(10.96) 
Total  518 
(100.00) 
236 
(100.00) 
67 
(100.00) 
821 
(100.00)  
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Figures in parenthesis indicates percentages,*Urinary 
Albumin Excretion, X
2 = 329.325, df= 4, p<0.001 
Figure-2:  Prevalence  of  Diabetic  Nephropathy 
among Males and Females (UAE) 
*Urinary Albumin Excretion 
 
Figure-3: Correlation between HbA1c and eGFR 
*estimated Glomerular Filtration Rate, , ** 
Glycosylated Haemoglobin 
This  finding  agrees  with  the  prevalence  report  of 
diabetic  nephropathy  in  type  2  diabetic  subjects, 
reported to be 5-9% in data analyzed from various 
Indian studies.
21-24 However, this value is much less 
when compared with the prevalence of the same in 
Asian-Indians  in  the  UK  (22.3%)  in  a  study 
conducted  by  Samanta  et  al. 
25  Once  overt 
nephropathy  occurs  without  specific  interventions, 
the  glomerular  filtration  rate  (GFR)  gradually  falls 
over a period of several years at a rate that is highly 
variable  from  individual  to  individual  (2-
20ml/min/year). 
26 In addition to its being the earlier 
manifestation of nephropathy, albuminuria is marker 
of  greatly  increased  cardiovascular  morbidity  and 
mortality  for  patients  with  T2DM. 
27  As  a  result, 
diabetic patients should be screened and  monitored 
regularly  for  microalbuminuria to avoid the risk of 
diabetic nephropathy complications. The relationship 
between HbA1c with eGFR and UAE as in figure-3 
&  4  respectively  showed  statistically  significance. 
This implies that urine albumin levels increased with 
HbA1c level.  
Figure-4: Correlation between HbA1c and UAE 
*Urinary  Albumin  Excretion,  **  Glycosylated 
Haemoglobin 
 
The  confounding  factors  for  microalbuminuria  like 
renal failure, urinary tract infection, hematuria, acute 
febrile  illness,  vigorous  exercise,  short  term 
pronounced  hyperglycemia,  uncontrolled 
hypertension  and  heart  failure  were  excluded  from 
the  study.  The  study  results  are  limited  to  cross-
sectional hospital based study and for multiple risk 
factor analysis a community based study needs to be 
undertaken with a larger sample size. 
 
Conclusion:Diabetic  Nephropathy  was  common  in 
south Indian type 2 DM and microalbuminuria was 
earliest  clinical  sign.  Progression  of  DN  can  be 
prevented  if  detected  early.  Poor  glycemic  control 
and duration of diabetes was associated with increase 
in  UAE  level  and  progression  of  CKD.  Hence 
screening for DN at the time of diagnosis in T2DM 
and  measures  to  reduce  albuminuria  at  earliest  can 
prevent further progression. Although the renal risk 
in diabetic nephropathy can be reduced by 20 to 40%, 
the fact remains that 70% still progress, justifying the 
attempts to develop novel approaches. It is important 
to  understand  the  epidemiological  aspects  of  the 
conditions and demographic pattern of the population 
along  with the pathophysiology and comprehensive 
management steps that need to be taken to prevent 
the progression of diabetic kidney disease. 
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